C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

Apellis Pharmaceuticals (NASDAQ:APLS) announced on Tuesday that the U.S. FDA approved its injectable medication Empaveli for ...

C3 Bullion, a pioneer in next-generation gold investment solutions, has launched its India operations, bringing its flagship ...

C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...

Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients aged 12 and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...

The XIAO Smart IR Mate is a compact circular-shaped IR remote hub/blaster built around the XIAO ESP32-C3 and designed for IoT ...

The Soundside Music Festival, scheduled to take place in September with headliners like the Killers, Hozier, and Vampire Weekend, has been canceled.

Inside the Wild Freeride Summer Camp Hosted by This MTB Legend originally appeared on BikeMag.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of C3.ai's market ...

The free summer concert series at the Museum of Early Trades & Crafts will continue with a performance by the C3 Soul Revue, ...